Neoplasms

Skin and Connective Tissue Diseases

All Conditions

Nervous System Diseases

Breast Neoplasms

Peripheral Nervous System Diseases

Breast Diseases

Skin Diseases

Antineoplastic Agents

All Drugs and Chemicals

Paclitaxel

Albumin-Bound Paclitaxel

This is an observational study, no interventions are specified

Christoph Salat, Prof.

The purpose of this non-interventional study is to collect data on the efficacy and safety of Nab-Paclitaxel in the routine application.

The main focus of this non-interventional study is set on answering the following questions:

* Can the results observed in controlled clinical trials regarding efficacy and safety be reproduced in the routine clinical setting?
* Are the side-effects of nab-paclitaxel therapy observed in this study comparable to the previously described safety-profile in terms of frequency and intensity?
* What are the main reasons for modification or termination of the nab-paclitaxel therapy?
* How does nab-paclitaxel therapy influence the patients' quality of life?
* What are the criteria for selecting nab-paclitaxel as therapy for metastatic breast cancer?

Non-interventional Study With Nab-Paclitaxel (Abraxane®)

Non-Interventional Study to Investigate Efficacy and Safety of Nab-Paclitaxel in Patients With Metastatic Breast Cancer

Assessed by questionnaires FACT-G, FACT-B, FACT-Taxanes and a pain questionnaire of the Robert-Koch-Institute.

iOMEDICO AG

Respiratory Tract (Lung and Bronchial) Diseases

Behaviors and Mental Disorders

Carcinoma, Non-Small-Cell Lung

Carcinoma

Lung Neoplasms

Neoplasms, Glandular and Epithelial

Neoplasms by Histologic Type

Respiratory Tract Neoplasms

Thoracic Neoplasms

Lung Diseases

Respiratory Tract Diseases

Carcinoma, Bronchogenic

Bronchial Neoplasms

Quality of Life

Antiemetics

Gastrointestinal Agents

Vinorelbine

Patients with advanced non-small cell lung cancer

Female patients with metastatic, Anthracycline-resistent breast cancer

The purpose of this non-interventional study is to collect data on efficacy and toxicity of the use of Navelbine ORAL in daily routine in Germany (especially after availability of an 80mg capsule). The study focusses on concomitant antiemetic therapy and patient compliance.

Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC)

Usage of Vinorelbin ORAL (Navelbine® ORAL) in the Treatment of Advanced Non-small Cell Lung Cancer(NSCLC)and Advanced Breast Cancer

Pierre Fabre Pharma GmbH

Study title	NCT ID	Conditions	Eligibility	Organization
Non-interventional Study With Nab-Paclitaxel (Abraxane®)	NCT01689610	Metastatic Brea...	18 Years -	iOMEDICO AG
Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC)	NCT00890903	Non Small Cell ... Metastatic Brea...	18 Years -	Pierre Fabre Pharma GmbH
Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC)	NCT00890903	Non Small Cell ... Metastatic Brea...	18 Years -	Pierre Fabre Pharma GmbH

Spots Global Cancer Trial Database for daily routine